Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.
Bejarano V, Quinn M, Conaghan PG, Reece R, Keenan AM, Walker D, Gough A, Green M, McGonagle D, Adebajo A, Jarrett S, Doherty S, Hordon L, Melsom R, Unnebrink K, Kupper H, Emery P; Yorkshire Early Arthritis Register Consortium.
Bejarano V, et al. Among authors: gough a.
Arthritis Rheum. 2008 Oct 15;59(10):1467-74. doi: 10.1002/art.24106.
Arthritis Rheum. 2008.
PMID: 18821658
Free article.
Clinical Trial.